Delivery Order SPE2DB20D2014-SPE2DB24FC95Q

Award Date 9/5/24
Potential Completion Date 9/6/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the supply of REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and has a ceiling value of $4,677.64. The contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which is valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,547.80 Firm Fixed Price Delivery Order is for the provision of REPATHA 140 MG/ML SURECLICKML, a specialty medication. The contract has a ceiling value of $1,547.80 and a completion date of July 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award, with ID SPE2DB24D2217|SPE2DB25FJVYA, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,345.76 delivery order contract is for the supply of REPATHA 140 MG/ML SURECLICKML, a specialty pharmaceutical product. The contract is a firm fixed-price, delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product, to the Defense Logistics Agency (DLA) by the prime contractor Amerisourcebergen Drug Corp. The award, valued at $1,016.82, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to supply a range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,536.46 firm fixed price delivery order is for the supply of REPATHA 140 MG/ML SURECLICK, a specialty medication. The contract has an ultimate completion date of April 19, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a $2,629.95 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of REPATHA 140 MG/ML SURECLICKML, a specialty medication, with a performance period through March 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,044.69 firm fixed-price Delivery Order contract is for the supply of REPATHA 140 MG/ML SURECLICKML, a medication used to treat cardiovascular conditions. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REPATHA 140 MG/ML SURECLICK, a medication, with a ceiling value of $3,045.89 and a period of performance through June 24, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award, valued at $4,938.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4568108388 REPATHA 140 MG/ML SURECLICKML. The contract is a Firm Fixed Price Delivery Order with a performance period through May 2, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $4,644.17 contract is for the supply of REPATHA 140 MG/ML SURECLICKML, a specialty medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical and...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC95Q
    Delivery Order

This federal contract award is for the delivery of REPATHA 140 MG/ML SURECLICKML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,840.98 firm fixed-price contract is a delivery order against an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The IDC is valued at up to $999,999,999 and is the primary vehicle for AmerisourceBergen to provide a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract does not have a set-aside designation.

Generated 12/5/24, 9:10 AM